Treatment of visceral leishmaniasis: model-based analyses on the spread of antimony-resistant L. donovani in Bihar, India.
BACKGROUND: Pentavalent antimonials have been the mainstay of antileishmanial therapy for decades, but increasing failure rates under antimonial treatment have challenged further use of these drugs in the Indian subcontinent. Experimental evidence has suggested that parasites which are resistant aga...
Saved in:
Main Authors: | Anette Stauch (Author), Hans-Peter Duerr (Author), Jean-Claude Dujardin (Author), Manu Vanaerschot (Author), Shyam Sundar (Author), Martin Eichner (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2012-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Model-based investigations of different vector-related intervention strategies to eliminate visceral leishmaniasis on the Indian subcontinent.
by: Anette Stauch, et al.
Published: (2014) -
Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and control.
by: Anette Stauch, et al.
Published: (2011) -
Arsenic exposure and outcomes of antimonial treatment in visceral leishmaniasis patients in Bihar, India: a retrospective cohort study.
by: Meghan R Perry, et al.
Published: (2015) -
Imipramine is an orally active drug against both antimony sensitive and resistant Leishmania donovani clinical isolates in experimental infection.
by: Sandip Mukherjee, et al.
Published: (2012) -
Visceral leishmaniasis and arsenic: an ancient poison contributing to antimonial treatment failure in the Indian subcontinent?
by: Meghan R Perry, et al.
Published: (2011)